Depression Evaluation Service - New York State Psychiatric Institute
New York, 10032, United States
NCT Number: NCT00296777
The main purpose of this study is to correlate brain testing with treatment outcome.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
New York, 10032, United States
40 medication-free Depressed Patients will receive a battery of neuropsychologic tests, standard dichotic listening tests, EEG, ERP and an f-MRI while performing a neuropsychologic test, the Simon. Once testing is completed, patients will be treated in an open treatment trial of SSRI. Non-responders will then receive Bupropion followed by Tricyclic Antidepressant if still depressed. While our main purpose is to correlate imaging testing with other measures of brain functioning, we also intend to see whether f-MRI findings demonstrate specific brain areas which differ between responders and non-responders. At the end of SSRI treatment, patients will have a second f-MRI scan to investigate any changes treatment and/or response may have caused.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 weeks: up to 40 mg/day
Other names: Lexapro
8 weeks: up to 450 mg/day (for patients without history of seizures or risk for developing seizures.
Other names: Wellbutrin
8 weeks: up to 300mg/day
*if patient does not have contraindication.
Other names: Tofranil, Pressamine
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
Time frame: 7 mos.
New York State Psychiatric Institute
Other
Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04235712
Depressive Disorder, Depressive Disorder, Major
Springfield, Massachusetts, United States
View Trial DetailsNCT04235725
Depressive Disorder, Depressive Disorder, Major
Washington D.C., District of Columbia, United States
View Trial DetailsNCT00296725
Depressive Disorder, Depressive Disorder Not Otherwise Specified
New York, United States
View Trial DetailsNCT00565110
Depressive Disorder, Depressive Disorder, Major
Los Angeles, California, United States
View Trial Details